Rossari Biotech Limited
Stock Forecast, Prediction & Price Target
Rossari Biotech Limited Financial Estimates
Rossari Biotech Limited Revenue Estimates
Rossari Biotech Limited EBITDA Estimates
Rossari Biotech Limited Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 3/31/2021 | 3/31/2022 | 3/31/2024 | 3/31/2026 | |||
Revenue
% change YoY
| ₹7.07B N/A | ₹14.75B 108.53% | ₹18.30B 24.09% | Avg: ₹24.62B Low: ₹23.51B High: ₹25.79B avg. 34.50% | |||
Net Income
% change YoY
| ₹802.2M N/A | ₹976.95M 21.78% | ₹1.30B 33.77% | Avg: ₹2.01B Low: ₹1.95B High: ₹2.11B avg. 54.29% | |||
EBITDA
% change YoY
| ₹1.30B N/A | ₹1.95B 49.52% | ₹2.57B 31.31% | Avg: ₹3.80B Low: ₹3.63B High: ₹3.98B avg. 47.95% | |||
EPS
% change YoY
| $15.58 N/A | $17.81 14.31% | $23.67 32.90% | Avg: $36.53 Low: $35.4 High: $38.2 avg. 54.30% | |||
Operating Expenses
% change YoY
| ₹1.28B N/A | ₹2.34B 82.24% | ₹5.21B 122.49% | Avg: ₹1.67B Low: ₹1.60B High: ₹1.75B avg. -67.82% | |||
FAQ
What is Rossari Biotech Limited stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 54.29% in 2026-2026.
We have gathered data from 4 analysts. Their low estimate is 1.95B, average is 2.01B and high is 2.11B.
What is Rossari Biotech Limited stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 34.50% in 2026-2026.
We have gathered data from 4 analysts. Their low revenue estimate is ₹23.51B, average is ₹24.62B and high is ₹25.79B.
What is Rossari Biotech Limited stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 54.30% in 2026-2026.
We have gathered data from 4 analysts. Their low earnings per share estimate is $35.4, average is $36.53 and high is ₹38.2.